Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.24.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 62,632 $ 155,714
Equity method investments 2,966,305 1,869,712
Receivables held-for-sale 35,299 85,254
Real estate 111,036 353,000
Investments 7,165 10,200
Securitization assets, net of allowance of $3 million and $0 million, respectively 218,946 177,032
Other assets 77,112 119,242
Total assets 6,552,350 4,760,148
Liabilities:    
Accounts payable, accrued expenses and other 163,305 120,114
Credit facilities 400,861 50,698
Commercial paper notes 30,196 192
Term loans payable 727,458 379,742
Senior unsecured notes 2,318,841 1,767,647
Convertible notes 609,608 344,253
Total Liabilities 4,410,725 3,095,402
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 112,174,279 and 90,837,008 shares issued and outstanding, respectively 1,122 908
Additional paid-in capital 2,381,510 1,924,200
Accumulated deficit (303,536) (285,474)
Accumulated other comprehensive income (loss) 13,165 (10,397)
Non-controlling interest 49,364 35,509
Total Stockholders’ Equity 2,141,625 1,664,746
Total Liabilities and Stockholders’ Equity 6,552,350 4,760,148
Non-recourse    
Liabilities:    
Non-recourse debt (secured by assets of $239 million and $632 million, respectively) 160,456 432,756
Commercial receivables    
Assets    
Receivables 2,983,170 1,887,483
Government receivables    
Assets    
Receivables $ 90,685 $ 102,511